XERS Xeris Biopharma Holdings, Inc.

NASDAQ
$10.71

Xeris Biopharma Holdings, Inc. (XERS) Earnings News

Earnings press releases, previews and reviews for Xeris Biopharma Holdings, Inc. (XERS), newest first. Our most recent is preview: Xeris Needs Recorlev's Expanded Sales Force to Deliver a Steep Second-Half Revenue Climb.